Expand chart
Reproduced from Kaiser Family Foundation Health Tracking Poll; Chart: Axios Visuals

The public believes research costs and industry profits are both big factors in drug pricing — a perception that's pretty well aligned with the reality of where pharma's money goes.

By the numbers: The Kaiser Family Foundation's latest tracking poll asked respondents to identify the "major factors" contributing to high drug prices. They could pick more than one.

  • 80% said industry profits are a major factor.
  • Smaller-but-still-pretty-big majorities cited the factors that drugmakers usually point to instead.
  • 69% identified research costs as a major cost driver, and 63% put "major" responsibility on pharmacy benefit managers.

On balance, the public seems skeptical of pharma.

  • Most people — 71% — said they trust drug companies to come up with new and effective drugs, and to be honest about those drugs' safety and effectiveness.
  • But just 25% said they trust the industry to price its products fairly.

Yes, but: This poll also indicates that drug prices aren’t a problem for most people.

  • 75% said it's easy to afford their prescriptions, and 45% said they pay less than $25 per month. Unsurprisingly, poorer people and those in worse health had a harder time covering their bills.

Go deeper: Pharma's research budgets are usually bigger than its profits

Go deeper

Updated 56 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 7 a.m. ET: 19,655,445 — Total deaths: 727,353 — Total recoveries — 11,950,845Map.
  2. U.S.: Total confirmed cases as of 7 a.m. ET: 4,998,802 — Total deaths: 162,425 — Total recoveries: 1,643,118 — Total tests: 61,080,587Map.
  3. Politics: Trump signs 4 executive actions on coronavirus aid — Democrats, and some Republicans, criticize the move.
  4. Public health: Fauci says chances are "not great" that COVID-19 vaccine will be 98% effective — 1 in 3 Americans would decline COVID-19 vaccine.
  5. Science: Indoor air is the next coronavirus frontline.
  6. Schools: How back-to-school is playing out in the South as coronavirus rages on — Princeton, Johns Hopkins, Howard to hold fall classes online.

Elevator anxiety will stifle reopenings

Illustration: Aïda Amer/Axios

Will you step back into an elevator any time soon?

Why it matters: Tens of billions of dollars — and the future of cities around the country — rest on the answer to that question. So long as workers remain unwilling to take elevators, hundreds of billions of dollars' worth of office real estate will continue to go largely unused.

Updated 6 hours ago - World

Brazil coronavirus death toll tops 100,000 and case numbers surpass 3 million

Brazilian President Jair Bolsonaro posted a photo of himself to Facebook congratulating his soccer team, Palmeiras, for winning the state title Saturday, moments after the health ministry confirmed the national COVID-19 death toll had surpassed 100,000.

Why it matters: Brazil is only the second country to confirm more than 100,000 deaths from the coronavirus. On Sunday morning, it became the second country to surpass 3 million cases, per Johns Hopkins. Only the U.S. has reported more. Bolsonaro has yet to address the milestones. He has previously tested positive for COVID-19 three times, but he's downplayed the impact of the virus, which has crippled Brazil's economy.

Editor's note: This article has been updated with the latest coronavirus case numbers and more context.